International Journal of Surgical Research

Objective To study the effect of methylprednisolone combined with azithromycin in the treatment of mycoplasma pneumoniae lobar pneumonia in children. Methods: This study was conducted from November 2021 to February 2022.1. The subjects were 80 children with mycoplasma pneumoniae lobar pneumonia admitted to our hospital during the above period. According to the different groups of treatment methods, they were divided into study group and control group. 40 children in the study group received methylprednisolone combined with azithromycin, while the children in the control group received symptomatic treatment and azithromycin treatment, To evaluate the effect of two groups of children after treatment. Results: After treatment, the time of cough disappearance, fever abatement and hospitalization were shorter than those in the control group (P<0.05); The effective rate of treatment in the study group was significantly higher than that in the control group (P<0.05). Conclusion: Methylprednisolone combined with azithromycin can achieve ideal therapeutic effect in the treatment of mycoplasma pneumoniae lobar pneumonia in children, and the symptoms of children will subside rapidly after treatment, which is worth using.

methylprednisolone; Azithromycin; Combined therapy; Pneumonia in children; Mycoplasma lobar pneumonia